Search

Search Constraints

You searched for: Author/Creator Hauser, Stephen

Search Results

1. 061 Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE). Issue 6 (24th May 2018)

3. 177 Updated safety analysis of ocrelizumab in multiple sclerosis. Issue 12 (14th November 2019)

8. Evaluation of no evidence of progression or active disease (nepad) in patients with primary progressive multiple sclerosis in the oratorio trial. Issue 5 (8th May 2017)

9. Identification of MS-specific serum miRNAs in an international multicenter study. Issue 5 (September 2018)

10. Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO. Issue 6 (7th December 2020)